14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $141.16 $183.01 Friday, 3rd May 2024 CYTK stock ended at $65.27. This is 1.45% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 2.47% from a day low at $65.00 to a day high of $66.61.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical Cytokinetics prices

Date Open High Low Close Volume
May 13, 2020 $21.06 $21.93 $20.50 $21.61 2 123 458
May 12, 2020 $20.95 $22.99 $20.81 $20.96 1 874 654
May 11, 2020 $19.38 $21.69 $18.43 $20.99 6 034 540
May 08, 2020 $16.11 $16.49 $15.65 $15.76 492 969
May 07, 2020 $16.01 $16.49 $14.89 $15.73 844 032
May 06, 2020 $16.40 $16.88 $16.26 $16.63 732 481
May 05, 2020 $15.85 $17.05 $15.53 $16.42 663 349
May 04, 2020 $14.16 $15.22 $14.11 $15.17 562 895
May 01, 2020 $14.85 $14.85 $13.87 $14.49 628 959
Apr 30, 2020 $15.98 $16.05 $14.88 $15.11 563 007
Apr 29, 2020 $16.40 $16.56 $15.73 $16.28 746 078
Apr 28, 2020 $16.00 $16.30 $15.40 $16.07 2 500 080
Apr 27, 2020 $15.78 $15.92 $15.64 $15.65 679 994
Apr 24, 2020 $15.64 $15.85 $15.22 $15.68 881 906
Apr 23, 2020 $15.12 $15.88 $15.12 $15.47 677 214
Apr 22, 2020 $15.31 $15.43 $14.91 $15.09 526 124
Apr 21, 2020 $15.41 $15.50 $14.67 $15.02 395 796
Apr 20, 2020 $15.00 $15.61 $14.96 $15.51 1 216 846
Apr 17, 2020 $14.57 $15.29 $13.76 $15.24 1 198 836
Apr 16, 2020 $14.19 $14.22 $13.45 $13.99 755 863
Apr 15, 2020 $13.33 $14.05 $13.08 $13.93 640 646
Apr 14, 2020 $13.85 $14.19 $13.28 $13.55 960 634
Apr 13, 2020 $14.06 $14.20 $13.45 $13.88 628 315
Apr 09, 2020 $14.71 $14.85 $13.68 $13.89 1 137 890
Apr 08, 2020 $12.33 $12.92 $12.19 $12.76 714 422
Click to get the best stock tips daily for free!

About Cytokinetics

Cytokinetics Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in pati... CYTK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT